Questions about how to manage your stress? Ask our Mindfulness Expert! RSVP now Questions about how to manage your stress? Ask our Mindfulness Expert! RSVP now
“I never imagined the online course would be so comprehensive, enjoyable, and easy to follow! ”
“After treatment, I was in a free fall. The Anticancer Lifestyle Program caught me and gave me the support I really needed.”
My breast cancer diagnosis was a wake up call. The Diet module helped me to learn the science behind the food rules I followed while raising my kids and has motivated me to get back to that healthier way of cooking and eating. Thank you!
Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study from the National Institutes of Health. The researchers found no associations with uterine cancer for other hair products that the women reported using, including hair dyes, bleach, highlights, or perms.
The study data includes 33,497 U.S. women ages 35-74 participating in the Sister Study, a study led by the National Institute of Environmental Health Sciences (NIEHS), part of NIH, that seeks to identify risk factors for breast cancer and other health conditions. The women were followed for almost 11 years and during that time 378 uterine cancer cases were diagnosed.
The researchers found that women who reported frequent use of hair straightening products, defined as more than four times in the previous year, were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products.
“We estimated that 1.64% of women who never used hair straighteners would go on to develop uterine cancer by the age of 70; but for frequent users, that risk goes up to 4.05%,” said Alexandra White, Ph.D., head of the NIEHS Environment and Cancer Epidemiology group and lead author on the new study. “This doubling rate is concerning. However, it is important to put this information into context – uterine cancer is a relatively rare type of cancer.”